{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030312","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.401922+00:00","generated_at":"2026-05-23T18:25:00.495248+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bluejay Diagnostics raises ~$3.7M via warrant inducement; existing holders exercise at reduced price","bullets":["Entered inducement agreements to exercise 1,085,106 Class C warrants at reduced exercise price of $3.42/share (down from $16.30).","Gross proceeds ~$3.7M; issued new Class E warrants for 1,085,106 shares exercisable at $3.42 through April 8, 2030.","Issued 682,203 common shares at closing; pre-funded warrants for 402,903 shares to avoid beneficial ownership limits.","Paid Aegis Capital Corp. $385,000 financial advisory fee; transaction closed April 8, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030312","json":"https://secwatch.observer/filing/0001213900-25-030312.json","markdown":"https://secwatch.observer/filing/0001213900-25-030312.md","text":"https://secwatch.observer/filing/0001213900-25-030312.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/0001213900-25-030312-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/ea0237671-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:25:00.495248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}